−2.50 TWD
−361.64 M TWD
63.43 M TWD
143.96 M
About GOLDEN BIOTECHNOLOGY CORP
Sector
CEO
Ching Tien Su
Headquarters
New Taipei
Website
Founded
2002
ISIN
TW0004132006
FIGI
BBG000QY0PZ2
Golden Biotechnology Corp. is a biopharmaceutical company which produces drugs and herbal supplement. It mainly focuses on discovery and clinical development of innovative therapeutic new drugs (NCE) and products that prevent and treat diseases. The company specialized in anti-cancer and anti-atherosclerosis drugs. It drugs preparation and applications in oncology, cardio-metabolic syndromes, autoimmune diseases, neurodegenerative diseases and infectious diseases. Golden Biotechnology was founded by Sheng Yung Liu and Li Yu Wu on September 27, 2002 and is headquartered in New Taipei, Taiwan.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 4132 is 15.10 TWD — it has increased by 0.67% in the past 24 hours. Watch GOLDEN BIOTECHNOLOGY CORP stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TPEX exchange GOLDEN BIOTECHNOLOGY CORP stocks are traded under the ticker 4132.
4132 stock has fallen by −1.31% compared to the previous week, the month change is a −11.44% fall, over the last year GOLDEN BIOTECHNOLOGY CORP has showed a −58.20% decrease.
4132 reached its all-time high on Jan 7, 2022 with the price of 314.75 TWD, and its all-time low was 14.85 TWD and was reached on Dec 11, 2024. View more price dynamics on 4132 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
4132 stock is 3.70% volatile and has beta coefficient of −0.41. Track GOLDEN BIOTECHNOLOGY CORP stock price on the chart and check out the list of the most volatile stocks — is GOLDEN BIOTECHNOLOGY CORP there?
Today GOLDEN BIOTECHNOLOGY CORP has the market capitalization of 2.42 B, it has decreased by −1.32% over the last week.
Yes, you can track GOLDEN BIOTECHNOLOGY CORP financials in yearly and quarterly reports right on TradingView.
4132 net income for the last half-year is −160.80 M TWD, while the previous report showed −218.52 M TWD of net income which accounts for 26.41% change. Track more GOLDEN BIOTECHNOLOGY CORP financial stats to get the full picture.
No, 4132 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 21, 2024, the company has 110.00 employees. See our rating of the largest employees — is GOLDEN BIOTECHNOLOGY CORP on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GOLDEN BIOTECHNOLOGY CORP EBITDA is −327.93 M TWD, and current EBITDA margin is −495.92%. See more stats in GOLDEN BIOTECHNOLOGY CORP financial statements.
Like other stocks, 4132 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GOLDEN BIOTECHNOLOGY CORP stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GOLDEN BIOTECHNOLOGY CORP technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GOLDEN BIOTECHNOLOGY CORP stock shows the strong sell signal. See more of GOLDEN BIOTECHNOLOGY CORP technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.